Literature DB >> 7479946

Antagonism of WT1 activity by protein self-association.

P Moffett1, W Bruening, H Nakagama, N Bardeesy, D Housman, D E Housman, J Pelletier.   

Abstract

Germline loss-of-function mutations at the Wilms tumor (WT) suppressor locus WT1 are associated with a predisposition to WTs and mild genital system anomalies. In contrast, germ-line missense mutations within the WT1 gene encoding the DNA-binding domain often yield a more severe phenotype consisting of WT, sexual ambiguity, and renal nephropathy. In this report, we demonstrate that the products of mutant alleles that impair DNA recognition can antagonize WT1-mediated transcriptional repression. We demonstrate that WT1 can self-associate in vitro and in vivo and that the responsible domain maps to the amino-terminal region of the protein. Oligomers of full-length protein form less efficiently or produce less stable complexes than oligomers between truncated polypeptides and full-length protein. Our data suggest a molecular mechanism to explain how WT1 mutations may act in deregulating cellular proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479946      PMCID: PMC40580          DOI: 10.1073/pnas.92.24.11105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos.

Authors:  M A Blanar; W J Rutter
Journal:  Science       Date:  1992-05-15       Impact factor: 47.728

2.  WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins.

Authors:  J C Reddy; J C Morris; J Wang; M A English; D A Haber; Y Shi; J D Licht
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

3.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

4.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

Review 5.  Genetics of Wilms' tumor.

Authors:  E Matsunaga
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.

Authors:  M Gessler; A Poustka; W Cavenee; R L Neve; S H Orkin; G A Bruns
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

7.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Authors:  J Pelletier; W Bruening; C E Kashtan; S M Mauer; J C Manivel; J E Striegel; D C Houghton; C Junien; R Habib; L Fouser
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

8.  Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.

Authors:  M J Coppes; G J Liefers; P Paul; H Yeger; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.

Authors:  W Bruening; N Bardeesy; B L Silverman; R A Cohn; G A Machin; A J Aronson; D Housman; J Pelletier
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

10.  Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

Authors:  M H Little; J Prosser; A Condie; P J Smith; V Van Heyningen; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

View more
  25 in total

Review 1.  Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?

Authors:  A Koziell; R Grundy
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

3.  The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.

Authors:  Yeou-cherng Bor; Jennifer Swartz; Avril Morrison; David Rekosh; Michael Ladomery; Marie-Louise Hammarskjöld
Journal:  Genes Dev       Date:  2006-05-31       Impact factor: 11.361

4.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.

Authors:  L W Ellisen; N Carlesso; T Cheng; D T Scadden; D A Haber
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

6.  Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.

Authors:  Lihua Dong; Stefan Pietsch; Zenglai Tan; Birgit Perner; Ralph Sierig; Dagmar Kruspe; Marco Groth; Ralph Witzgall; Hermann-Josef Gröne; Matthias Platzer; Christoph Englert
Journal:  J Am Soc Nephrol       Date:  2015-01-02       Impact factor: 10.121

Review 7.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

8.  A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.

Authors:  C E Patek; M H Little; S Fleming; C Miles; J P Charlieu; A R Clarke; K Miyagawa; S Christie; J Doig; D J Harrison; D J Porteous; A J Brookes; M L Hooper; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 9.  Tumour suppressor gene mutations in humans and mice: parallels and contrasts.

Authors:  M L Hooper
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

Review 10.  The role of WT1 in oncogenesis: tumor suppressor or oncogene?

Authors:  David M Loeb; Saraswati Sukumar
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.